Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

nintedanib 150 MG Oral Capsule [Ofev]

Known as: Ofev 150 MG (as nintedanib ethanesulfonate 180.6 MG) Oral Capsule, Ofev 150 MG Oral Capsule 
 
National Institutes of Health

Related topics

Related topics

3 relations
Oral Capsulenintedanib

Broader (1)

nintedanib Oral Capsule [Ofev]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Nintedanib: New indication for systemic sclerosis-associated interstitial lung disease
Abstract Nintedanib (Ofev™), an oral triple kinase inhibitor targeting pro-fibrotic pathways, has been used for treatment of… Expand
2016
2016
Évolution potentielle du danger d'incendie de forêt dans le contexte des changements climatiques
Chaque année en Suisse, une centaine de feux de forêt sont enregistrés – principalement dans les Alpes – et environ 300 hectares… Expand
2016
2016
Cost-effectiveness of nintedanib ( Ofev ® ) for the treatment of Idiopathic Pulmonary Fibrosis
  • 2016
    • Corpus ID: 33090112
The HSE asked the National Centre for Pharmacoeconomics (NCPE) to carry out an assessment of the applicant’s (Boehringer… Expand
2016
2016
Pirfenidon — skuteczny lek w leczeniu samoistnego włóknienia płuc
Samoistne wloknienie pluc (SWP) jest przewleklą postepującą chorobą ograniczoną do pluc, prowadzącą do restrykcyjnych zaburzen… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE